Skip Nav Destination
Issues
July 2008
ISSN 0001-5792
EISSN 1421-9662
Acta Haematologica 2008, Vol. 119, No. 4
Molecular Drug Targets in Myeloproliferative Neoplasms
Mutant Molecules of Interest in Myeloproliferative Neoplasms: Introduction
Acta Haematol (2008) 119 (4): 192–193.
https://doi.org/10.1159/000140629
RAS Pathway Mutations in Juvenile Myelomonocytic Leukemia
Acta Haematol (2008) 119 (4): 207–211.
https://doi.org/10.1159/000140632
BCR-ABL in Chronic Myelogenous Leukemia – How Does It Work?
Acta Haematol (2008) 119 (4): 212–217.
https://doi.org/10.1159/000140633
JAK2 and MPL Mutations in Myeloproliferative Neoplasms
Acta Haematol (2008) 119 (4): 218–225.
https://doi.org/10.1159/000140634
Original Paper
Leukemic Cluster Growth in Culture Is an Independent Risk Factor for Acute Myeloid Leukemia and Short Survival in Patients with Myelodysplastic Syndrome
Michael Bernimoulin; Martin Stern; André Tichelli; Martine Jotterand; Alois Gratwohl; Catherine Nissen
Acta Haematol (2008) 119 (4): 226–235.
https://doi.org/10.1159/000140675
Case Report
Brief Communication
Von Willebrand Factor-Specific Antibodies Developing upon Treatment of FVIII-Deficient Mice with Different FVIII Preparations
Acta Haematol (2008) 119 (4): 244–247.
https://doi.org/10.1159/000142614
Further Section
Author Index Vol. 119, 2008
Acta Haematol (2008) 119 (4): 248–249.
https://doi.org/10.1159/000148716